ATE471985T1 - Protease from lucilia sericata und deren verwendung zur wundheilung - Google Patents

Protease from lucilia sericata und deren verwendung zur wundheilung

Info

Publication number
ATE471985T1
ATE471985T1 AT00969689T AT00969689T ATE471985T1 AT E471985 T1 ATE471985 T1 AT E471985T1 AT 00969689 T AT00969689 T AT 00969689T AT 00969689 T AT00969689 T AT 00969689T AT E471985 T1 ATE471985 T1 AT E471985T1
Authority
AT
Austria
Prior art keywords
amc
lucilia sericata
proteolytic activity
activity against
protease
Prior art date
Application number
AT00969689T
Other languages
English (en)
Inventor
David Idris Pritchard
Original Assignee
Secr Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Secr Defence filed Critical Secr Defence
Application granted granted Critical
Publication of ATE471985T1 publication Critical patent/ATE471985T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43577—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Materials Engineering (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00969689T 1999-10-22 2000-10-20 Protease from lucilia sericata und deren verwendung zur wundheilung ATE471985T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9925005.2A GB9925005D0 (en) 1999-10-22 1999-10-22 The treatment of wounds
PCT/GB2000/004034 WO2001031033A2 (en) 1999-10-22 2000-10-20 Protease from lucila sericata and its use in treatment of wounds

Publications (1)

Publication Number Publication Date
ATE471985T1 true ATE471985T1 (de) 2010-07-15

Family

ID=10863184

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00969689T ATE471985T1 (de) 1999-10-22 2000-10-20 Protease from lucilia sericata und deren verwendung zur wundheilung

Country Status (7)

Country Link
US (2) US7144721B1 (de)
EP (1) EP1222285B1 (de)
AT (1) ATE471985T1 (de)
AU (1) AU7934500A (de)
DE (1) DE60044584D1 (de)
GB (1) GB9925005D0 (de)
WO (1) WO2001031033A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE29924318U1 (de) * 1999-01-14 2002-09-19 Fleischmann Wilhelm Verbandsmaterial
US20080108551A1 (en) * 2006-07-06 2008-05-08 The Secretary Of State For Defence Treatment of wounds
DE10138303A1 (de) * 2001-08-10 2003-03-06 Aventis Pharma Gmbh Verwendung von Enzymisolaten aus Fliegenlarven zur Wundbehandlung
GB0127618D0 (en) * 2001-11-17 2002-01-09 Univ Nottingham "Composition and method for treatment of wounds"
GB0205593D0 (en) * 2002-03-09 2002-04-24 Univ Nottingham Treatment of surfaces populated by bacteria
DE10342104A1 (de) * 2003-09-10 2005-06-09 Fleischmann, Wilhelm, Dr.med. Verfahren zur Herstellung eines Mittels zur Wundbehandlung und nach diesem Verfahren hergestelltes Mittel
DE102005061246A1 (de) * 2005-12-20 2007-06-28 Alpha-Biocare Gmbh Präparate mit niedermolekularen Substanzen aus Dipteren zur Behandlung von Wunden
GB0607495D0 (en) * 2006-04-13 2006-05-24 Secr Defence Larval enzymes
GB0610697D0 (en) * 2006-05-31 2006-07-12 Secr Defence Larval enzyme
US20100008898A1 (en) * 2006-05-31 2010-01-14 David Idris Pritchard Chymotrypsin from lucilia sericata larvae and its use for the treatment of wounds
GB0700946D0 (en) * 2007-01-18 2007-02-28 Uws Ventures Ltd Antimicrobial composition and a method of controlling contamination and infection using said composition
EP2226382A1 (de) * 2009-03-03 2010-09-08 B.R.A.I.N. Biotechnology Research and Information Network AG Protease zur Wundbehandlung und Hautpflege
US10513696B2 (en) 2016-05-24 2019-12-24 Hamzeh Alipour Lucilia sericata collagenase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987007907A1 (en) 1986-06-17 1987-12-30 Celltech Limited Process for the production of a protein
US5352664A (en) 1986-10-31 1994-10-04 Board Of Regents, The University Of Texas System Thrombin derived polypeptides; compositions and methods for use
US5688768A (en) 1991-02-19 1997-11-18 Cor Therapeutics, Inc. Recombinant thrombin receptor and related pharmaceuticals
US5892014A (en) 1996-10-30 1999-04-06 The Regents Of The University Of California DNA encoding a protease-activated receptor 3
WO1999043809A2 (en) 1998-02-27 1999-09-02 The Regents Of The University Of California Protease-activated receptor 4 and uses thereof

Also Published As

Publication number Publication date
GB9925005D0 (en) 1999-12-22
EP1222285A2 (de) 2002-07-17
DE60044584D1 (de) 2010-08-05
WO2001031033A3 (en) 2001-09-20
US20070066538A1 (en) 2007-03-22
AU7934500A (en) 2001-05-08
WO2001031033A2 (en) 2001-05-03
EP1222285B1 (de) 2010-06-23
US7144721B1 (en) 2006-12-05

Similar Documents

Publication Publication Date Title
ATE471985T1 (de) Protease from lucilia sericata und deren verwendung zur wundheilung
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
DE69734661D1 (de) Foerderung der wundheilung durch chemisch modifizierte tetracycline
DE69625691T2 (de) Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten
DE60027894D1 (de) Milchsäurebakterienkombination und deren verwendung zur behandlung und prävention von infektionen und entzündungen
ATE357272T1 (de) Verwendung von phthalazin-derivaten zur behandlung neurodegenerativer krankheiten
ATE512650T1 (de) Hydrogelwundverband und zugehöriges herstellungs- und benutzungsverfahren
DE69836752D1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
CA2322502A1 (en) Protease inhibitors in absorbent articles
DE69939481D1 (de) Methode zur behandlung von diabetes die einen ap2-inhibitor und dazugehörige kombinationen verwendet
EA200400482A1 (ru) Кератиноциты, пригодные для применения в качестве биологически активной субстанции при лечении ран
DE60324777D1 (de) Verwendung von il-18-inhibitoren zur behandlung und/oder prävention von peripheren gefässkrankheiten
ATE277943T1 (de) Trypsininhibitoren
EP0832100A4 (de) Neuartige metalloprotease-inhibitoren, diese enthaltende pharmazeutische zusammensetzungen und anwendungsverfahren
HK1073438A1 (en) Furin inhibitors for use in the treatment of fibrosis and scarring
DE60017133D1 (de) Naphthochinonderivate und ihre verwendung zur behandlung und kontrolle von tuberkulose
EP0728481A3 (de) Verwendun von Chinoxalinen in Kombination mit Protease-Inhibitoren als Arzneimittel zur Behandlung von AIDS und/oder HIV-Infektionen
DE69519602T2 (de) Kugelförmige Aktivkohle zur Behandlung von Hämorrhoiden
DE69729735D1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
DE59704933D1 (de) Verwendung von PHMB zur Behandlung von Tumorerkrankungen
DE60123833D1 (de) Entwurf und verwendung von verbesserten zink-chelatbildenden peptiden zur regulation von matrix-metalloproteinasen
IL138594A0 (en) Use of protease inhibitors for treating skin wounds
WO1998030212A3 (de) Verwendung von aminothiazolen zur verbesserung der wundheilung
JP2005518355A5 (de)
WO2007075853A3 (en) Protease compositions for the treatment of damaged tissue

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties